A critical breakthrough in cancer investigation is emerging with the use of VHH fragments to re-engage dysfunctional p53. This essential malignant inhibitor protein is frequently disabled in various types of https://ok-social.com/story7548471/mini-antibodies-restore-tumor-suppressor-p53-the-potential-hope-for-tumor-management